Quantcast

Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.

Research paper by I I Bobyr, A A Campanati, A A Giacchetti, A A Offidani

Indexed on: 29 Jan '19Published on: 29 Jan '19Published in: Photodermatology, Photoimmunology & Photomedicine



Abstract

Actinic keratosis (AK) is the most common cutaneous intraepithelial neoplasm that typically develops on sun-damaged skin of elderly patients. Some untreated AK lesions may progress into invasive squamous cell carcinoma (iSCC) (1). Treatments for AKs could be classified in "lesion-directed treatments" including cryotherapy, laser, curettage, and dermabrasion; "field-directed treatments" including imiquimod, PDT, ingenol mebutate, diclofenac and piroxicam (1). This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.